Researchers have developed a non-chemotherapy treatment regimen that is achieving full remissions for some people with aggressive B-cell lymphoma that has come back or is no longer responding to standard treatments. The five-drug combination targets multiple molecular pathways that diffuse large B-cell lymphoma (DLBCL) tumors use to survive.
source https://www.sciencedaily.com/releases/2024/06/240619182323.htm
Committed skeptic finds himself warming to new Amazon AI products that
actually don't suck
-
If you live long enough, you'll wake up one day and find that you're living
in a world you no longer understand. Lately there are things happening with
AI ...
2 days ago
No comments:
Post a Comment